Skip to main content

Advertisement

SpringerLink
Log in

Assessing Medication Appropriateness in the Elderly

A Review of Available Measures

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

The disproportionate use of medications, combined with age-related pharmacokinetic and pharmacodynamic changes, places older adults at high risk for medication related problems (MRPs). MRPs demonstrate significant morbidity, mortality and economic impact among healthcare systems. The negative outcomes associated with MRPs emphasise the need for more careful and thorough assessments of drug therapy among older adults.

In the 1990s a number of methods and instruments were developed to assist in the assessment of medication appropriateness. These tools may be categorised by criteria as: implicit, explicit or one utilising a combination of implicit and explicit criteria. This article reviews these available tools and outlines the advantages and disadvantages of each. In conclusion, those instruments considered to be comprised of both implicit and explicit criteria offer a more thorough assessment of medication appropriateness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Fig. 1

Similar content being viewed by others

References

  1. Hall WJ. Update in geriatrics. Ann Intern Med 1997; 127(7): 557–64

    PubMed  CAS  Google Scholar 

  2. Stewart RB. Drag use in the elderly. In: Delafuente JC, Stewart RB, editors. Therapeutics in the elderly. 2nd ed. Cincinnati: Harvey Whitney Books, 1995: 174–89

    Google Scholar 

  3. Broderick E. Prescribing patterns for nursing home residents in the US: the reality and the vision. Drags Aging 1997; 11: 255–60

    Article  CAS  Google Scholar 

  4. Chrischilles EA, Foley DJ, Wallace RB, et al. Use of medications by persons 65 and over: data from the Established Populations for Epidemiologic Studies of the Elderly. J Gerontol 1992; 47: M137–44

    Article  PubMed  CAS  Google Scholar 

  5. Chrischilles EA, Segar ET, Wallace RB. Self-reported adverse drag reactions and related resource use: a study of community-dwelling persons 65 years of age and older. Ann Intern Med 1992; 117: 634–40

    PubMed  CAS  Google Scholar 

  6. Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997; 45: 945–8

    PubMed  CAS  Google Scholar 

  7. May JR. Adverse drug reactions and interactions. In: Dipiro JT, Talbert RL, Yee GC, et al., editors. Pharmacotherapy: apathophysiologic approach. 3rd ed. Stamford: Appleton and Lange, 1997: 101–16

    Google Scholar 

  8. Rochon PA, Gurwitz JH. Optimising drag treatment for elderly people: the prescibing cascade. BMJ 1997; 315: 1096–9

    Article  PubMed  CAS  Google Scholar 

  9. Graves T, Hanlon JT, Schmader KE, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med 1997; 157: 2205–10

    Article  PubMed  CAS  Google Scholar 

  10. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs and attributable mortality. JAMA 1997; 277(4): 301–6

    Article  PubMed  CAS  Google Scholar 

  11. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5

    Article  PubMed  CAS  Google Scholar 

  12. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med 1995; 155: 1949–56

    Article  PubMed  CAS  Google Scholar 

  13. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drag events: implications for prevention. JAMA 1995; 274: 29–34

    Article  PubMed  CAS  Google Scholar 

  14. Beers MH, Storrie M, Lee G. Potential adverse drag interactions in the emergency room: an issue in the quality of care. Ann Intern Med 1990; 112: 61–4

    PubMed  CAS  Google Scholar 

  15. Costa AJ. Potential drug interactions in an ambulatory geriatric population. Fam Practice 1991; 8: 234–6

    Article  CAS  Google Scholar 

  16. Gosney M, Tallis R. Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet 1984; II: 564–7

    Article  Google Scholar 

  17. Jankel CA, McMillan JA, Martin BC. Effect of drag interactions on outcomes of patients receiving warfarin or theophylline. Am J Hosp Pharm 1994; 51: 661–6

    PubMed  CAS  Google Scholar 

  18. Hamilton RA, Gordon T. Incidence and cost of hospital admissions secondary to drug interactions involving theophylline. Ann Pharmacother 1992; 26: 1507–11

    PubMed  CAS  Google Scholar 

  19. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531–6

    Article  PubMed  CAS  Google Scholar 

  20. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330: 592–6

    Article  PubMed  CAS  Google Scholar 

  21. Perez-Stable EJ, Miranda J, Munoz RF, et al. Depression in medical outpatients: underrecognition and misdiagnosis. Arch Intern Med 1990; 150: 1083–8

    Article  PubMed  CAS  Google Scholar 

  22. Gurwitz JH, Monette J, Rochon PA, et al. Atrial fibrillation and stroke prevention with warfarin the long-term care setting. Arch Intern Med 1997; 157: 978–84

    Article  PubMed  CAS  Google Scholar 

  23. Stuck AE, Tamai IY. Medication management in the home. Clin Geriatr Med 1991; 7(4): 733–48

    PubMed  CAS  Google Scholar 

  24. Monane M, Monane S, Semla T. Optimal medication use in elders: key to successful aging. West J Med 1997; 167: 233–7

    PubMed  CAS  Google Scholar 

  25. Montamat SC, Cusack BJ, Vestal RE. Management of drag therapy in the elderly. N Engl J Med 1989; 321: 303–9

    Article  PubMed  CAS  Google Scholar 

  26. Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684–9

    PubMed  CAS  Google Scholar 

  27. Spore DL, Mor V, Larrat P, et al. Inappropriate drag prescriptions for elderly residents of board and care facilities. Am J Pub Health 1997; 87: 404–9

    Article  CAS  Google Scholar 

  28. Aparasu RR, Fliginger SE. Inappropriate medication prescribing for the elderly by office-based physicians. Ann Pharmacother 1997; 31: 823–9

    PubMed  CAS  Google Scholar 

  29. Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Questionable prescribing for elderly patients in Quebec. Can Med Assoc J 1994; 150(11): 1801–9

    CAS  Google Scholar 

  30. Torrible SJ, Hogan DB. Medication use and rural seniors: who really knows what they are taking? Can Fam Physician 1997; 43: 893–989

    PubMed  CAS  Google Scholar 

  31. Der EH, Rubenstein LZ, Choy GS. The benefits of in-home pharmacy evaluation for older persons. J Am Geriatr Soc 1997; 45(2): 211–4

    Google Scholar 

  32. Hunter KA, Florio ER, Langberg RG. Pharmaceutical care for home-dwelling elderly persons: a determination of need and program description. Gerontologist 1996; 36(4): 543–8

    Article  PubMed  CAS  Google Scholar 

  33. Schrader SL, Dressing B, Blue R, et al. The Medication Reduction Project: combatting polypharmacy in South Dakota elders through community-based interventions. S D J Med 1996; 49(12): 441–8

    PubMed  CAS  Google Scholar 

  34. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825–32

    Article  PubMed  CAS  Google Scholar 

  35. Shelton PS, Hanlon JT, Landsman PB, et al. Reliability of drug utilization evaluation as an assessment of medication appropriateness. Ann Pharmacother 1997; 31: 533–42

    PubMed  CAS  Google Scholar 

  36. Morris JN, Hawes C, Murphy K, et al. Resident assessment instrument training manual and resource guide. Natick (MA): Eliot Press, 1991

    Google Scholar 

  37. Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045–51

    Article  PubMed  CAS  Google Scholar 

  38. Hamdy RC, Moore SW, Whalen K, et al. Reducing polypharmacy in extended care. South Med J 1995; 88(5): 534–8

    Article  PubMed  CAS  Google Scholar 

  39. Owens NJ, Sherburne NJ, Silliman RA, et al. The Senior Care Study: the optimal use of medications in acutely ill older patients. J Am Geriatr Soc 1990; 38: 1082–7

    PubMed  CAS  Google Scholar 

  40. Johnson RE, Campbell WH, Azevedo DJ, et al. Studying the impact of patient drag profiles in an HMO. Med Care 1976; 14: 799–807

    Article  PubMed  CAS  Google Scholar 

  41. Koepsell TD, Gurtel AL, Diehr PH, et al. The Seattle evaluation of computerized drag profiles: effects on prescribing practice and resource use. Am J Pub Health 1983; 73: 850–5

    Article  CAS  Google Scholar 

  42. Tamai IY, Rubenstein LZ, Josephson KR, et al. Impact of computerized drag profiles and a consulting pharmacist on outpatient prescribing patterns: a clinical trial. Drag Intell Clin Pharm 1987; 21: 890–5

    CAS  Google Scholar 

  43. Stuck AE, Beers MH, Steiner A, et al. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994; 154: 2195–200

    Article  PubMed  CAS  Google Scholar 

  44. Anderson GM, Beers MH, Kerluke K. Auditing prescription practice using explicit criteria and computerized drug benefit claims data. J Evalu Clin Pract 1997; 3(4): 283–94

    Article  CAS  Google Scholar 

  45. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994; 272(4): 292–6

    Article  PubMed  CAS  Google Scholar 

  46. McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 1997; 156(3): 385–91

    CAS  Google Scholar 

  47. Oborne CA, Batty GM, Maskrey V, et al. Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 1997; 43: 91–7

    Article  PubMed  CAS  Google Scholar 

  48. Knapp DA. Development of criteria for drug utilization review. Clin Pharm Ther 1991; 50(5): 600–5

    CAS  Google Scholar 

  49. Davidson HE, Chamberlain TM, Hernandez P, et al. Drug-use evaluation, part II: Drug-use analysis in pharmaceutical care and quality assurance. Consult Pharmacist 1991; 6(10): 836–43

    Google Scholar 

  50. Ben-Joseph R, Segal R, Russell WL, et al. Evaluating the value, accuracy and operational feasibility of DUE criteria. Formulary 1995; 30: 280–3

    PubMed  CAS  Google Scholar 

  51. Winslade NE, Bajcare JM, Bombassaro AM, et al. Pharmacist’s management of drug-related problems: a tool for teaching and providing pharmaceutical care. Pharmacotherapy 1997; 17(4): 801–9

    PubMed  CAS  Google Scholar 

  52. Robertson KE. Process for preventing or identifying and resolving problems in drug therapy. Am J Health Syst Pharm 1996; 53: 639–50

    PubMed  CAS  Google Scholar 

  53. Newton PF, Levinson W, Maslen D. The Geriatric Medication Algorithm: a pilot study. J Gen Intern Med 1994; 9(3): 164–7

    Article  PubMed  CAS  Google Scholar 

  54. Lipton HL, Bird JA, Bero LA, et al. Assessing the appropriateness of physician prescribing for geriatric outpatients: development and testing of an instrument. J Pharm Technol 1993; 9: 107–13

    PubMed  CAS  Google Scholar 

  55. Owens NJ, Fretwell MD, Willey C, et al. Distinquishing between the fit and frail elderly, and optimising pharmacotherapy. Drugs Aging 1994; 4(1): 47–55

    Article  PubMed  CAS  Google Scholar 

  56. Morris JN, Hawes C, Fries BE, et al. Designing the national resident assessment instrument for nursing homes. Gerontologist 1990; 30: 293–307

    Article  PubMed  CAS  Google Scholar 

  57. Riley K. Putting the MDS 2.0 to work in long-term care. Consult Pharmacist 1996; 11(7): 669–75

    Google Scholar 

  58. Riley K. RAPs and the consultant pharmacist. Consult Pharmacist 1997; 12(1): 32–4

    Google Scholar 

  59. Morris JN, Fries BE, Knight S, et al. Comprehensive clinical assessment in community setting: applicability of the MDSHC. J Am Geriatr Soc 1997; 45: 1017–24

    PubMed  CAS  Google Scholar 

  60. Morris JN, Nonemaker S, Murphy K, et al. A commitment to change: revision of HCFA’s RAI. J Am Geriatr Soc 1997; 45: 1011–16

    PubMed  CAS  Google Scholar 

  61. Ouslander JG. The resident assessment instrument (RAI): promises and pitfalls. J Am Geriatr Soc 1997; 45: 975–6

    PubMed  CAS  Google Scholar 

  62. Losben NL. Putting the MDS 2.0 to work to identify and monitor at-risk elderly. Consult Pharmacist 1997; 12(5): 520–34

    Google Scholar 

  63. Tobias DE, Feinberg JL, Troutman WG. The MDS-Med Guide: a tool for the new millenium. Consult Pharmacist 1999; 14(8): 831–60

    Google Scholar 

  64. Samsa GP, Hanlon JT, Schmader KE, et al. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994; 47: 891–6

    Article  PubMed  CAS  Google Scholar 

  65. Schmader KE, Hanlon JT, Weinberger M, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994; 42: 1241–7

    PubMed  CAS  Google Scholar 

  66. Schmader KE, Hanlon JT, Landsman PB, et al. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother 1997; 31: 529–33

    PubMed  CAS  Google Scholar 

  67. Fitzgerald LS, Hanlon JT, Shelton PS, et al. Reliability of a modified medication appropriateness index in ambulatory older persons. Ann Pharmacother 1997; 31: 543–8

    PubMed  CAS  Google Scholar 

  68. Naranjo CA, Busto U, Sellers EM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45

    Article  PubMed  CAS  Google Scholar 

  69. Kramer MS, Leventhal JM, Hutchinson TA, et al. An algorithm for the operational assessment of adverse drug reactions. J Am Med Assoc 1979; 242: 623–32

    Article  CAS  Google Scholar 

  70. Hepler DC, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533–43

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Resources for Seniors, Inc., Raleigh, North Carolina, USA

    Penny S. Shelton (MEDS Program Director)

  2. Department of Pharmacy Practice, Campbell University, North Carolina, USA

    Michelle A. Fritsch & Mollie A. Scott

  3. Alamance Regional Medical Center, Burlington, North Carolina, USA

    Michelle A. Fritsch

  4. Department of Community & Family Medicine, Duke University Medical Center, Durham, North Carolina, USA

    Mollie A. Scott

Authors
  1. Penny S. Shelton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelle A. Fritsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mollie A. Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Penny S. Shelton.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shelton, P.S., Fritsch, M.A. & Scott, M.A. Assessing Medication Appropriateness in the Elderly. Drugs & Aging 16, 437–450 (2000). https://doi.org/10.2165/00002512-200016060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200016060-00004

Keywords

Search

Navigation